GB2020665A - Acyl-N-acetylmuramylpeptide- antigen conjugate - Google Patents
Acyl-N-acetylmuramylpeptide- antigen conjugateInfo
- Publication number
- GB2020665A GB2020665A GB7909795A GB7909795A GB2020665A GB 2020665 A GB2020665 A GB 2020665A GB 7909795 A GB7909795 A GB 7909795A GB 7909795 A GB7909795 A GB 7909795A GB 2020665 A GB2020665 A GB 2020665A
- Authority
- GB
- United Kingdom
- Prior art keywords
- acyl
- antigen
- conjugate
- group
- acetylmuramylpeptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
- C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
- C07K9/005—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure containing within the molecule the substructure with m, n > 0 and m+n > 0, A, B, D, E being heteroatoms; X being a bond or a chain, e.g. muramylpeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Transplantation (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Crystallography & Structural Chemistry (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
An acyl-N-acetylmuramyl peptide derivative-antigen conjugate, in which more than one of the hydroxyl groups in N-acetylglucosamine are substituted with acyl group, particularly with mycoloyl group to give the compound lipophilic property; and a di- or tripeptide is introduced as a spacer into the carboxyl group, thereby binding an antigen through its amino acid; and to a process for the preparation of said conjugate. On administration to an animal, the conjugate selectively suppresses the production of IgE antibody by an antigen later administered and thus may be applied for prevention or treatment of atopic disease without suppressing the normal immune response.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP3790178A JPS54130516A (en) | 1978-03-31 | 1978-03-31 | Acyllnnacetylmuramylpeptide derivativeeantigen combination |
Publications (1)
Publication Number | Publication Date |
---|---|
GB2020665A true GB2020665A (en) | 1979-11-21 |
Family
ID=12510433
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB7909795A Withdrawn GB2020665A (en) | 1978-03-31 | 1979-03-20 | Acyl-N-acetylmuramylpeptide- antigen conjugate |
Country Status (4)
Country | Link |
---|---|
JP (1) | JPS54130516A (en) |
DE (1) | DE2912865A1 (en) |
FR (1) | FR2421178A1 (en) |
GB (1) | GB2020665A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10610564B2 (en) | 2015-02-26 | 2020-04-07 | Stc.Unm | IRGM and precision autophagy controls for antimicrobial and inflammatory disease states and methods of detection of autophagy |
WO2020109792A1 (en) * | 2018-11-28 | 2020-06-04 | Pedanius Therapeutics Limited | Antibacterial antisense agents |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2482958A2 (en) * | 1979-06-29 | 1981-11-27 | Rhone Poulenc Ind | Immunostimulant and adjuvant L-alanyl-D-glutamyl tri:peptide derivs. - in which the C-terminal aminoacid is l-lysine or di:amino-pimelic acid and which has a fatty acid n-acyl gp. |
FR2482959A2 (en) * | 1979-06-29 | 1981-11-27 | Rhone Poulenc Ind | Merrifield synthesis of immunostimulant and adjuvant tri:peptide(s) - produces fatty acid acrylated l-alanine d-glutamic acid 2-lysine or 2,6-di:amino-pimelamic acid cpds. |
DK156252C (en) * | 1979-07-31 | 1989-12-18 | Fujisawa Pharmaceutical Co | METHOD OF ANALOGUE FOR THE PREPARATION OF DI, TRIAL OR TETRAPEPTIDE DERIVATIVES OR SALTS THEREOF |
DE3070278D1 (en) * | 1979-10-11 | 1985-04-18 | Fujisawa Pharmaceutical Co | Peptides, processes for their preparation and pharmaceutical compositions containing them |
FR2477551A1 (en) * | 1980-03-10 | 1981-09-11 | Anvar | NEW DERIVATIVES OF A-TREHALOSE AND MEDICAMENTS CONTAINING SAME |
FR2546756B1 (en) * | 1983-06-03 | 1985-11-29 | Centre Nat Rech Scient | NOVEL IMMUNOSTIMULATING DERIVATIVES, THEIR PREPARATION AND THEIR APPLICATION AS MEDICAMENTS |
US4877795A (en) * | 1987-01-30 | 1989-10-31 | Kissei Pharmaceutical Co., Ltd. | 4H-quinolizin-4-one compounds useful for the treatment of allergic bronchial asthma, allergic rhinitis atropic dermatitis and the like |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH538003A (en) * | 1968-03-29 | 1973-01-31 | Anvar | Process for obtaining textile articles carrying enzymes |
US4186194A (en) * | 1973-10-23 | 1980-01-29 | Agence Nationale De Valorisation De La Recherche (Anvar) | Water soluble agents effective as immunological adjuvants for stimulating, in the host the immune response to various antigens and compositions, notably vaccines containing said water soluble agents |
EP0003833B2 (en) * | 1978-02-24 | 1990-12-19 | Ciba-Geigy Ag | Antigen derivatives, process for their preparation, pharmaceutical compositions containing them |
-
1978
- 1978-03-31 JP JP3790178A patent/JPS54130516A/en active Pending
-
1979
- 1979-03-20 GB GB7909795A patent/GB2020665A/en not_active Withdrawn
- 1979-03-30 DE DE19792912865 patent/DE2912865A1/en active Pending
- 1979-04-02 FR FR7908265A patent/FR2421178A1/en not_active Withdrawn
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10610564B2 (en) | 2015-02-26 | 2020-04-07 | Stc.Unm | IRGM and precision autophagy controls for antimicrobial and inflammatory disease states and methods of detection of autophagy |
WO2020109792A1 (en) * | 2018-11-28 | 2020-06-04 | Pedanius Therapeutics Limited | Antibacterial antisense agents |
GB2579253A (en) * | 2018-11-28 | 2020-06-17 | Pedanius Therapeutics Ltd | Antibacterial antisense agents |
Also Published As
Publication number | Publication date |
---|---|
FR2421178A1 (en) | 1979-10-26 |
DE2912865A1 (en) | 1979-10-18 |
JPS54130516A (en) | 1979-10-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Nakamura et al. | Effect of IFN-γ on the immune response in vivo and on gene expression in vitro | |
DE60103066T2 (en) | CHLORELLA PREPARATIONS WITH IMMUNOMODULATIVE PROPERTIES | |
JPS5461112A (en) | Oncostatic polysaccharide* its preparation* and oncostatic drugs containing it as an effective component | |
CA2040374A1 (en) | Process for enhancing the resistance of aquatic animals to disease | |
KR880000098A (en) | Chondroitin Sulfate Immunostimulatory Composition | |
IL65875A0 (en) | Capsules containing the active principle of an allergen,and process for their preparation | |
JPS568320A (en) | Drug for tumor immunotherapy comprising lipopolysaccharide as active constituent | |
GB2020665A (en) | Acyl-N-acetylmuramylpeptide- antigen conjugate | |
GB1395090A (en) | Stabilized hormone compositions | |
Bondy | Axonal transport of macromolecules I. Protein migration in the central nervous system | |
OHNO et al. | Antitumor effect of protein-bound polysaccharide preparation, PS-K, against 3-methylcholanthrene-induced fibrosarcoma in C57BL/6 mice | |
EP0282343A3 (en) | Method to stimulate the immune response to specific antigens | |
Suzuki et al. | Inhibition by Lipopolysaccharide (Endotoxin) of Antibody Response of Rabbit to Common Antigen of Enterobacteriaceae. | |
Schmidt et al. | Immunodiffusion reactions with rubella antigens | |
GB1355961A (en) | Preparation of immunosuppressive antilymphocytic serum | |
ATE109004T1 (en) | TOLERANCE INDUCTION TO A FOREIGN ANTIGEN. | |
Atkins et al. | Studies on the structure and distribution of immunoglobulin A-containing cells in the gut of the pig. | |
KR910700259A (en) | How T-cell Recognized Peptide Modifications Influence the Immune Response | |
Rosan et al. | Toxicity of Lactobacillus casei | |
Isenberg et al. | Immunological and toxic differences between mouse-virulent and mouse-avirulent Candida albicans | |
Koga et al. | Immunological Adjuvants | |
Taniyama et al. | Purification of polysaccharide antigen from Leptospira biflexa strain Urawa | |
Dalen et al. | Antibodies against extractable components from Propionibacterium acnes in humans with and without acne vulgaris | |
JPS5522641A (en) | Antiallergic agent | |
Gold et al. | Comparison of Polypeptide Chains of γG-Globulin from Bursectomized and Normal Chickens. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WAP | Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1) |